BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30400820)

  • 1. Sulfatide decreases the resistance to stress-induced apoptosis and increases P-selectin-mediated adhesion: a two-edged sword in breast cancer progression.
    Suchanski J; Grzegrzolka J; Owczarek T; Pasikowski P; Piotrowska A; Kocbach B; Nowak A; Dziegiel P; Wojnar A; Ugorski M
    Breast Cancer Res; 2018 Nov; 20(1):133. PubMed ID: 30400820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role for sulfatides in platelet aggregation.
    Merten M; Thiagarajan P
    Circulation; 2001 Dec; 104(24):2955-60. PubMed ID: 11739312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galactosylceramide affects tumorigenic and metastatic properties of breast cancer cells as an anti-apoptotic molecule.
    Owczarek TB; Suchanski J; Pula B; Kmiecik AM; Chadalski M; Jethon A; Dziegiel P; Ugorski M
    PLoS One; 2013; 8(12):e84191. PubMed ID: 24391908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-galactosylceramide increases and sulfatide decreases cytokine and chemokine production in whole blood cells.
    Roeske-Nielsen A; Fredman P; Mansson JE; Bendtzen K; Buschard K
    Immunol Lett; 2004 Feb; 91(2-3):205-11. PubMed ID: 15019291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfatides activate platelets through P-selectin and enhance platelet and platelet-leukocyte aggregation.
    Merten M; Beythien C; Gutensohn K; Kühnl P; Meinertz T; Thiagarajan P
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):258-63. PubMed ID: 15528476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-selectin mediates metastatic progression through binding to sulfatides on tumor cells.
    Garcia J; Callewaert N; Borsig L
    Glycobiology; 2007 Feb; 17(2):185-96. PubMed ID: 17043066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin-induced protein (PIP) increases the sensitivity of breast cancer cells to drug-induced apoptosis.
    Urbaniak A; Jablonska K; Suchanski J; Partynska A; Szymczak-Kulus K; Matkowski R; Maciejczyk A; Ugorski M; Dziegiel P
    Sci Rep; 2023 Apr; 13(1):6574. PubMed ID: 37085653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of soluble E-selectin on tumor progression and metastasis.
    Kang SA; Blache CA; Bajana S; Hasan N; Kamal M; Morita Y; Gupta V; Tsolmon B; Suh KS; Gorenstein DG; Razaq W; Rui H; Tanaka T
    BMC Cancer; 2016 May; 16():331. PubMed ID: 27220365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of SM4 sulfatide as a P-selectin ligand using model membranes.
    Simonis D; Schlesinger M; Seelandt C; Borsig L; Bendas G
    Biophys Chem; 2010 Aug; 150(1-3):98-104. PubMed ID: 20163908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfatide binding and activation of leukocytes through an L-selectin-independent pathway.
    Ding Z; Kawashima H; Miyasaka M
    J Leukoc Biol; 2000 Jul; 68(1):65-72. PubMed ID: 10914491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endosomes and lysosomes play distinct roles in sulfatide-induced neuroblastoma apoptosis: potential mechanisms contributing to abnormal sulfatide metabolism in related neuronal diseases.
    Zeng Y; Cheng H; Jiang X; Han X
    Biochem J; 2008 Feb; 410(1):81-92. PubMed ID: 17939778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of elevated sulfatides and sulfotransferase activities with human renal cell carcinoma.
    Sakakibara N; Gasa S; Kamio K; Makita A; Koyanagi T
    Cancer Res; 1989 Jan; 49(2):335-9. PubMed ID: 2562926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD62/P-selectin binding sites for myeloid cells and sulfatides are overlapping.
    Bajorath J; Hollenbaugh D; King G; Harte W; Eustice DC; Darveau RP; Aruffo A
    Biochemistry; 1994 Feb; 33(6):1332-9. PubMed ID: 7508745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfatide-selectin signaling in the spinal cord induces mechanical allodynia.
    Morita M; Watanabe S; Nomura N; Takano-Matsuzaki K; Oyama M; Iwai T; Tanabe M
    J Neurochem; 2023 Mar; 164(5):658-670. PubMed ID: 36528843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfatide inhibits HIV-1 entry into CD4-/CXCR4+ cells.
    Fantini J; Hammache D; Delézay O; Piéroni G; Tamalet C; Yahi N
    Virology; 1998 Jul; 246(2):211-20. PubMed ID: 9657940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells.
    Cooney CA; Jousheghany F; Yao-Borengasser A; Phanavanh B; Gomes T; Kieber-Emmons AM; Siegel ER; Suva LJ; Ferrone S; Kieber-Emmons T; Monzavi-Karbassi B
    Breast Cancer Res; 2011 Jun; 13(3):R58. PubMed ID: 21658254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth inhibitor affects the invasion, apoptosis and vascularisation in breast cancer cell line MDA-MB-231.
    Gao Y; Ge Z; Zhang Z; Bai Z; Ma X; Wang Y
    Chin Med J (Engl); 2014; 127(10):1947-53. PubMed ID: 24824261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of tumour cell ECM degradation by thrombin-activated platelet membranes: potentially a P-selectin and GPIIb/IIIa-dependent process.
    Pang JH; Coupland LA; Freeman C; Chong BH; Parish CR
    Clin Exp Metastasis; 2015 Jun; 32(5):495-505. PubMed ID: 25982688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfatides are associated with neointimal thickening after vascular injury.
    Inoue T; Taguchi I; Abe S; Li G; Hu R; Nakajima T; Hara A; Aoyama T; Kannagi R; Kyogashima M; Node K
    Atherosclerosis; 2010 Jul; 211(1):291-6. PubMed ID: 20176357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEA-15 inhibits tumorigenesis in an MDA-MB-468 triple-negative breast cancer xenograft model through increased cytoplasmic localization of activated extracellular signal-regulated kinase.
    Bartholomeusz C; Gonzalez-Angulo AM; Kazansky A; Krishnamurthy S; Liu P; Yuan LX; Yamasaki F; Liu S; Hayashi N; Zhang D; Esteva FJ; Hortobagyi GN; Ueno NT
    Clin Cancer Res; 2010 Mar; 16(6):1802-11. PubMed ID: 20215547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.